Roche

Data Science in the Pharmaceutical Industry: A Coursera Specialisation

The Pharmaceutical industry is adopting new tools and technologies, putting pressure on individuals to learn many new skills in a short period of time. In order to both promote these new ways of working, and to assist those adopting it, at Genentech …

How CI/CD Enhances the Development of R packages in the Pharmaverse

Continuous integration (CI) and continuous delivery (CD) are playing a pivotal role in ensuring that R projects in Pharma meet the highest quality standards. Particular focus is placed on ensuring that packages are fit for purpose both on internal …

Pharmaverse: Breaking boundaries through open source collaboration!

Roche/Genentech, GSK, Atorus and J&J/Janssen have initiated a collaboration called pharmaverse to bring together a curated subset of open-source R packages to enable clinical reporting (from CRF to eSubmission). Where gaps are identified, new …

R pilot submissions to FDA

On Nov 22nd, 2021, the R Consortium R Submissions Working Group successfully submitted an R-based test submission package through the FDA eCTD gateway. The submission package has been received by the FDA staff who were able to reproduce the numerical …

Roches approach to software validation: an automated pipeline from validation to publication

Over the past year, we’ve designed a process that is meant to mimic public package publishing as closely as possible, where packages are automatically assessed by a series of checks which may prompt manual revision should the automated processing …

Working at the intersection of Biostatistics and Software Engineering in a Pharma company

Increasingly biostatisticians in pharma companies would like to use R on a daily basis, e.g. the growing number of participants in R/Pharma conferences is one metric showing this trend. As R programs replace proprietary software in this regulated …

Smoothing out our path to open source and pan-pharma code collaboration

In recent years late stage Pharma has begun to transition from a consumer of open source, and a sporadic creator, to a heavily invested collaborator on open source tools like R packages. In this short talk, James will discuss our recent focus on open …

R Consortium Pharma Working Groups Overview and Updates

In this talk, we would like to provide updates on the four biopharmaceutical industry focused R consortium cross-industry working groups. These working groups have a similar overall objective to support the use of R within the biopharmaceutical …

5 testing packages to make your package better!

In this short talk I will present few packages that can be used inside package testing framework that will help to increase overall quality of a package. The main point of focus would be static R code analysis tools such as well-known codetools …

Introducing {admiral}—The ADaM in R Asset Library

abstract to follow